Back to Agenda
GVP Module XVI - Risk minimisation measures: Selection of tools and effectiveness indicators (REV 3)- cont.
Speaker(s)
METHODS FOR EFFECTIVENESS EVALUATION OF RISK MINIMISATION MEASURES (RMMs)
Thomas Goedecke, PharmD, PhD
Senior Pharmacovigilance Specialist, European Medicines Agency, Netherlands
MONITORING THE EFFECTIVENESS OF RMMs: FROM THEORY TO PRACTISE
Daniel Morales, MD, PhD, MRCP
Epidemiologist, European Medicines Agency, Netherlands
Q&A AND PANEL DISCUSSION INCLUDING:
Priya Bahri, PhD
Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy), European Medicines Agency, Netherlands
Q&A AND PANEL DISCUSSION INCLUDING:
Viola Macolic Sarinic, DRSc, MD, MSc
Scientific Officer, European Medicines Agency, Netherlands
Have an account?